Matthew Harrison
Stock Analyst at Morgan Stanley
(3.43)
# 1,006
Out of 4,667 analysts
749
Total ratings
48.56%
Success rate
3.65%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $473 → $476 | $448.01 | +6.25% | 36 | Nov 5, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $1,235 → $1,184 | $744.60 | +59.01% | 50 | Nov 1, 2024 | |
| BIIB Biogen | Downgrades: Equal-Weight | $285 → $204 | $155.43 | +31.25% | 50 | Oct 31, 2024 | |
| AVNT Avient | Downgrades: Neutral | n/a | $49.89 | - | 1 | Oct 18, 2024 | |
| IOBT IO Biotech | Maintains: Overweight | $4 → $6 | $0.87 | +589.66% | 5 | Sep 16, 2024 | |
| AVIR Atea Pharmaceuticals | Upgrades: Equal-Weight | $2 → $6.88 | $3.14 | +119.11% | 9 | Aug 13, 2024 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $7 → $6 | $3.22 | +86.34% | 9 | Jul 29, 2024 | |
| INSM Insmed | Maintains: Overweight | $60 → $85 | $73.72 | +15.30% | 15 | Jul 12, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Overweight | $165 → $200 | $106.62 | +87.58% | 34 | Jun 24, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Equal-Weight | $8 → $11 | $16.83 | -34.64% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $2.99 | +167.56% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $574.54 | -11.23% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.48 | +182.26% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $78 | $87.75 | -11.11% | 37 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $61.97 | +80.73% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $20.51 | +65.77% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $20.50 | +56.10% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $319 | $187.77 | +69.89% | 27 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.17 | +499.37% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $14 | $2.27 | +516.74% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $10 | $3.85 | +159.74% | 9 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $123 | $37.29 | +229.85% | 23 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $85 | $38.40 | +121.35% | 10 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $3 | $0.31 | +883.28% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $42.32 | +8.70% | 1 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $61 → $63 | $24.34 | +158.83% | 11 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $3.04 | +327.63% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.77 | +30.31% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.09 | -47.62% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $3.01 | +165.78% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $26.69 | +64.86% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $2.36 | +450.85% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $1.11 | +260.36% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.56 | +434.66% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $106.40 | +103.01% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $2.06 | +142.72% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.22 | +125.23% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $166.57 | +9.26% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $5.64 | +59.57% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $31.03 | +28.91% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $279.95 | +0.73% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $234.27 | -10.36% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $27 | $0.56 | +4,727.46% | 7 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.10 | +107.17% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $153.00 | +13.07% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $4.91 | +1,060.90% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $45.13 | +165.90% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $46.30 | +219.65% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $96.54 | -15.06% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $58.23 | +13.34% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.12 | +1,739.62% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $26.01 | +76.86% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $14.59 | +139.89% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $729.73 | -62.31% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.00 | +850.00% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $9.56 | +548.54% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.54 | -1.65% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $1.16 | +4,210.34% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $70.56 | +17.63% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $17.57 | +224.42% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $51.09 | -80.43% | 4 | Sep 10, 2018 |
Vertex Pharmaceuticals
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $473 → $476
Current: $448.01
Upside: +6.25%
Regeneron Pharmaceuticals
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $744.60
Upside: +59.01%
Biogen
Oct 31, 2024
Downgrades: Equal-Weight
Price Target: $285 → $204
Current: $155.43
Upside: +31.25%
Avient
Oct 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $49.89
Upside: -
IO Biotech
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $0.87
Upside: +589.66%
Atea Pharmaceuticals
Aug 13, 2024
Upgrades: Equal-Weight
Price Target: $2 → $6.88
Current: $3.14
Upside: +119.11%
2seventy bio
Jul 29, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $3.22
Upside: +86.34%
Insmed
Jul 12, 2024
Maintains: Overweight
Price Target: $60 → $85
Current: $73.72
Upside: +15.30%
Sarepta Therapeutics
Jun 24, 2024
Maintains: Overweight
Price Target: $165 → $200
Current: $106.62
Upside: +87.58%
Centessa Pharmaceuticals
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $16.83
Upside: -34.64%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $2.99
Upside: +167.56%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $574.54
Upside: -11.23%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.48
Upside: +182.26%
Apr 26, 2024
Maintains: Equal-Weight
Price Target: $80 → $78
Current: $87.75
Upside: -11.11%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $61.97
Upside: +80.73%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $20.51
Upside: +65.77%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $20.50
Upside: +56.10%
Aug 29, 2023
Maintains: Overweight
Price Target: $321 → $319
Current: $187.77
Upside: +69.89%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.17
Upside: +499.37%
Aug 10, 2023
Maintains: Overweight
Price Target: $13 → $14
Current: $2.27
Upside: +516.74%
Aug 7, 2023
Reiterates: Equal-Weight
Price Target: $10
Current: $3.85
Upside: +159.74%
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $128 → $123
Current: $37.29
Upside: +229.85%
Jul 20, 2023
Maintains: Overweight
Price Target: $65 → $85
Current: $38.40
Upside: +121.35%
Jul 11, 2023
Reiterates: Underweight
Price Target: $3
Current: $0.31
Upside: +883.28%
Apr 24, 2023
Reiterates: Buy
Price Target: $46
Current: $42.32
Upside: +8.70%
Apr 12, 2023
Maintains: Overweight
Price Target: $61 → $63
Current: $24.34
Upside: +158.83%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $3.04
Upside: +327.63%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.77
Upside: +30.31%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.09
Upside: -47.62%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $3.01
Upside: +165.78%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $26.69
Upside: +64.86%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $2.36
Upside: +450.85%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $1.11
Upside: +260.36%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.56
Upside: +434.66%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $106.40
Upside: +103.01%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.06
Upside: +142.72%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.22
Upside: +125.23%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $166.57
Upside: +9.26%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $5.64
Upside: +59.57%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $31.03
Upside: +28.91%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $279.95
Upside: +0.73%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $234.27
Upside: -10.36%
Sep 9, 2022
Maintains: Overweight
Price Target: $32 → $27
Current: $0.56
Upside: +4,727.46%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.10
Upside: +107.17%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $153.00
Upside: +13.07%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $4.91
Upside: +1,060.90%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $45.13
Upside: +165.90%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $46.30
Upside: +219.65%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $96.54
Upside: -15.06%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $58.23
Upside: +13.34%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.12
Upside: +1,739.62%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $26.01
Upside: +76.86%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $14.59
Upside: +139.89%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $729.73
Upside: -62.31%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.00
Upside: +850.00%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $9.56
Upside: +548.54%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.54
Upside: -1.65%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $1.16
Upside: +4,210.34%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $70.56
Upside: +17.63%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $17.57
Upside: +224.42%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $51.09
Upside: -80.43%